Moreover, a greater proportion of participants on retatrutide 8 and 12 mg (7782%) achieved an HbA1c 6.5% compared to placebo (5%) and dulaglutide 1.5 mg (43%)
This is one of the most common pharmacy defaults, especially for patients who order larger vial sizes to reduce per-dose costs
Reported and Observed Side Effects Injection site reaction: Small, brief redness or mild soreness at the injection site
Drug-drug interactions may occur when two or more medicines are taken together, resulting in a higher risk of side effects or decreased efficacy of one or both medications
Adverse Reactions Nausea, vomiting, abdominal cramps, diarrhea, and a "fishy" body odor can occur with doses of about 3 g/day
The fullness signal after meals lasts longer